Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools

View the NIAID Selected Research Advances

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Technology Transfer and Intellectual Property

NIAID has been at the forefront of cutting-edge biomedical research for decades. The work performed in its labs has furthered the understanding of the immune system and led to significant advances in the fields of immunology and infectious disease research. But it's a long path from basic scientific discoveries to approved vaccines, treatments, or diagnostic tools. NIAID is constantly pursuing collaborations with industry and academia to develop its technologies and materials into products that improve public health. The Technology Transfer and Intellectual Property Office facilitates collaborative relationships between NIAID investigators and the broader scientific community.

View Slides

Highlighted Licensing and Collaboration Opportunities

Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine

Arsenical Compounds as Therapeutics for Inflammatory Diseases

Anthrax Fusion Toxins With Improved Ability To Penetrate Cells

Multi-Specific Chimeric Antigen Receptors Against HIV

Complete list of Recent Licensing and Collaboration Opportunities

Recent Happenings

United States patent 9,012,618 was issued on April 21, 2015, for “Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures.” NIAID inventor: Nancy Sullivan, Ph.D.

NIAID and MedImmune/AstraZeneca signed a cooperative research and development agreement (CRADA) to study the development of live, attenuated vaccines for pandemic influenza. NIAID principal investigator: Kanta Subbarao, M.B.B.S., M.P.H.

Complete list of Technology Development Recent Happenings

Last Updated May 21, 2015